021-51111890
购物车（）
sales@molnova.cn
COH34
CAS No. 906439-72-3
COH34 ( -[(E)-(4-methylphenyl)sulfanyliminomethyl]naphthalen-2-ol )
产品货号. M26126 CAS No. 906439-72-3
COH34 是 PARG 的选择性抑制剂，IC50 为 0.37 nM，Kd 为 0.547 μM。 COH34 延长 DNA 损伤处的 PARylation 并捕获 DNA 修复因子。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥2341 | 有现货 |
|
| 10MG | ￥3686 | 有现货 |
|
| 25MG | ￥6099 | 有现货 |
|
| 50MG | ￥8586 | 有现货 |
|
| 100MG | ￥11583 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称COH34
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述COH34 是 PARG 的选择性抑制剂，IC50 为 0.37 nM，Kd 为 0.547 μM。 COH34 延长 DNA 损伤处的 PARylation 并捕获 DNA 修复因子。
-
产品描述COH34 is a selective inhibitor of PARG with an IC50 of 0.37 nM and a Kd of 0.547 μM. COH34 prolongs PARylation at DNA lesions and traps DNA repair factors.(In Vitro):COH34 potently inhibits PARP inhibitor-resistant cancer cells.(In Vivo):COH34 shows antitumor activity in xenograft mouse cancer models.
-
体外实验COH34 efficiently kills PARP inhibitor-resistant cancer cells.
-
体内实验COH34 induces lethality in cancer cells with DNA repair defects and exhibits antitumor activity in xenograft mouse cancer models.
-
同义词-[(E)-(4-methylphenyl)sulfanyliminomethyl]naphthalen-2-ol
-
通路Others
-
靶点Other Targets
-
受体Cytidine deaminase
-
研究领域——
-
适应症——
化学信息
-
CAS Number906439-72-3
-
分子量293.38
-
分子式C18H15NOS
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 16.67 mg/mL (56.82 mM)
-
SMILESCc1ccc(S\N=C\c2c(O)ccc3ccccc23)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Funamizu N, et al. Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels. PLoS One. 2012;7(5):e37424.
产品手册
关联产品
-
Pidotimod
Pidotimod 是一种口服活性二肽免疫刺激剂 (immunostimulant)，具有适应性和先天免疫应答的免疫调节特性。Pidotimod 增加巨噬细胞活性和体液免疫功能。Pidotimod 可用于慢性支气管炎、慢性阻塞性肺疾病 (COPD)、支气管扩张、慢性特发性荨麻疹等的研究。
-
S961 TFA (1083433-49...
S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.
-
Angiogenin (108-122)...
Angiogenin (108-122) TFA is an angiogenin peptide.Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease.
